{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:00:44Z","timestamp":1790704844199,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"am","delay-in-days":394,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.encep.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T22:09:53Z","timestamp":1588543793000},"page":"S14-S34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S","title":["Informations relatives aux psychotropes et \u00e0 leurs adaptations \u00e9ventuelles pour les patients souffrant de troubles psychiques en France pendant l\u2019\u00e9pid\u00e9mie \u00e0 SARS-CoV-2"],"prefix":"10.1016","volume":"46","author":[{"given":"H.","family":"Javelot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Drapier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fakra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hingray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Egron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Straczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Roser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Haffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2020.04.006_bib0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.encep.2020.03.001","article-title":"Assurer les soins aux patients souffrant de troubles psychiques en France pendant l\u2019\u00e9pid\u00e9mie \u00e0 SARS-CoV-2","author":"Chevance","year":"2020","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2020.04.006_bib0410","unstructured":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/covid-19_consignes_services_psychiatrie.pdf [cit\u00e9 le 24\u00a0mars 2020]."},{"key":"10.1016\/j.encep.2020.04.006_bib0415","unstructured":"COVID-19\u00a0: recommandations du CGLPL relatives aux \u00e9tablissements de sant\u00e9 mentale [Internet]. Sant\u00e9 Mentale. [cit\u00e9 29\u00a0mars 2020]. https:\/\/www.santementale.fr\/actualites\/covid-19-recommandations-du-cglpl-relatives-aux-etablissements-de-sante-mentale.html."},{"key":"10.1016\/j.encep.2020.04.006_bib0420","unstructured":"Haute Autorit\u00e9 de sant\u00e9. https:\/\/www.has-sante.fr\/jcms\/p_3168631\/fr\/prise-en-charge-des-patients-souffrant-de-pathologies-psychiatriques-en-situation-de-confinement-a-leur-domicile Et le d\u00e9cret\u00a0: https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000041746744&dateTexte=&categorieLien=id."},{"key":"10.1016\/j.encep.2020.04.006_bib0425","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314\u00a0cases from the Chinese Center for Disease Control and Prevention","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"10229","key":"10.1016\/j.encep.2020.04.006_bib0430","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19\u00a0in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2020.04.006_bib0440","doi-asserted-by":"crossref","first-page":"m1198","DOI":"10.1136\/bmj.m1198","article-title":"Covid-19: risk factors for severe disease and death","volume":"368","author":"Jordan","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0445","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/jcm7020020","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.encep.2020.04.006_bib0450","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/2045125315612334","article-title":"A review of the management of antidepressant discontinuation symptoms","volume":"5","author":"Wilson","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0455","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.encep.2018.08.001","article-title":"Switching and stopping antidepressants","volume":"44","author":"Gauthier","year":"2018","journal-title":"Enc\u00e9phale"},{"issue":"5","key":"10.1016\/j.encep.2020.04.006_bib0460","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2019.052","article-title":"Stopping and switching antipsychotic drugs","volume":"42","author":"Keks","year":"2019","journal-title":"Aust Prescr"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0465","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000370338","article-title":"Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review","volume":"84","author":"Fava","year":"2015","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0470","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review","volume":"87","author":"Fava","year":"2018","journal-title":"Psychother Psychosom"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0480","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40266-020-00754-1","article-title":"Psychotropic drug-associated pneumonia in older adults","volume":"37","author":"Rajamaki","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.encep.2020.04.006_bib0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob"},{"issue":"6485","key":"10.1016\/j.encep.2020.04.006_bib0490","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.abb8034","article-title":"Misguided drug advice for COVID-19","volume":"367","author":"FitzGerald","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.encep.2020.04.006_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0500","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18773\/austprescr.2019.006","article-title":"The hot patient: acute drug-induced hyperthermia","volume":"42","author":"Jamshidi","year":"2019","journal-title":"Aust Prescr"},{"key":"10.1016\/j.encep.2020.04.006_bib0505","series-title":"Thesaurus des interactions m\u00e9dicamenteuses","author":"ANSM","year":"2019"},{"issue":"7","key":"10.1016\/j.encep.2020.04.006_bib0510","article-title":"Syndrome malin des neuroleptiques et syndrome s\u00e9rotoninergique\u00a0: diagnostics positifs et diff\u00e9rentiels et \u00e9tiologies m\u00e9dicamenteuses\u00a0!","volume":"14","author":"Montastruc","year":"2000","journal-title":"Lettre Pharmacol"},{"issue":"89","key":"10.1016\/j.encep.2020.04.006_bib0515","first-page":"819","article-title":"Le syndrome ou toxidrome s\u00e9rotoninergique\u00a0: \u00e9tiologies, signes cliniques centraux et p\u00e9riph\u00e9riques","volume":"10","author":"Spreux-Varoquaux","year":"2013","journal-title":"Info Psychiatr"},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0520","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.therap.2016.12.010","article-title":"The anticholinergic impregnation scale: towards the elaboration of a scale adapted to prescriptions in French psychiatric settings","volume":"72","author":"Briet","year":"2017","journal-title":"Therapie"},{"issue":"3","key":"10.1016\/j.encep.2020.04.006_bib0525","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/23328940.2015.1071701","article-title":"Psychogenic fever, functional fever, or psychogenic hyperthermia?","volume":"2","author":"Olivier","year":"2015","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.encep.2020.04.006_bib0530","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/B978-0-444-64074-1.00035-5","article-title":"Stress-induced hyperthermia and hypothermia","volume":"157","author":"Oka","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0535","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.1994.tb04259.x","article-title":"The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections","volume":"37","author":"Lowry","year":"1994","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.encep.2020.04.006_bib0540","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11908-011-0175-y","article-title":"Antipsychotic drug use and community-acquired pneumonia","volume":"13","author":"Trifir\u00f2","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"49","key":"10.1016\/j.encep.2020.04.006_bib0545","first-page":"834","article-title":"The differential diagnosis of dyspnea","volume":"113","author":"Berliner","year":"2016","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0550","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/flgastro-2013-100316","article-title":"Drug-induced gastrointestinal disorders","volume":"5","author":"Philpott","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.encep.2020.04.006_bib0555","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881108093582","article-title":"Problems associated with long-term treatment with selective serotonin reuptake inhibitors","volume":"23","author":"Moret","year":"2009","journal-title":"J Psychopharmacol"},{"issue":"11","key":"10.1016\/j.encep.2020.04.006_bib0560","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0269881118795333","article-title":"Antipsychotic drug use and pneumonia: systematic review and meta-analysis","volume":"32","author":"Dzahini","year":"2018","journal-title":"J Psychopharmacol"},{"issue":"10","key":"10.1016\/j.encep.2020.04.006_bib0565","doi-asserted-by":"crossref","first-page":"e0187034","DOI":"10.1371\/journal.pone.0187034","article-title":"Biological substantiation of antipsychotic-associated pneumonia: systematic literature review and computational analyses","volume":"12","author":"Sultana","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0570","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00223-2018","article-title":"Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia","volume":"5","author":"Boivin","year":"2019","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0575","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.4088\/JCP.12m07938","article-title":"Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study","volume":"74","author":"Yang","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2020.04.006_bib0580","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/jgs.13327","article-title":"Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study","volume":"63","author":"Paul","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0585","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jgs.13932","article-title":"Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control study","volume":"64","author":"Chatterjee","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0590","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/wps.20707","article-title":"Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics","volume":"19","author":"de Leon","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.encep.2020.04.006_bib0595","series-title":"Recommandation de bonne pratique en psychiatrie\u00a0: comment am\u00e9liorer la prise en charge somatique des patients ayant une pathologie psychiatrique s\u00e9v\u00e8re et chronique","author":"FFP-CNPP","year":"2015"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0600","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int J Bipolar Disord"},{"issue":"7","key":"10.1016\/j.encep.2020.04.006_bib0605","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00045391-199607000-00004","article-title":"Lithium withdrawal in bipolar disorder: implications for clinical practice and experimental therapeutics research","volume":"3","author":"Baldessarini","year":"1996","journal-title":"Am J Ther"},{"issue":"12","key":"10.1016\/j.encep.2020.04.006_bib0610","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3109\/00048674.2011.610296","article-title":"Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity","volume":"45","author":"Wijeratne","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2020.04.006_bib0615","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1503\/jpn.200061","article-title":"Consensus statement on the use of clozapine during the COVID-19\u00a0pandemic","volume":"45","author":"Siskind","year":"2020","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"10.1016\/j.encep.2020.04.006_bib0620","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00228-010-0925-z","article-title":"Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies?","volume":"67","author":"Wagner","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.encep.2020.04.006_bib0625","doi-asserted-by":"crossref","DOI":"10.1002\/pnp.272","article-title":"Toxic levels of clozapine in a patient with acute urethritis","author":"Yadav","year":"2013","journal-title":"Prog Neurol Psychiatry"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0630","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10020105","article-title":"Focus on clozapine withdrawal- and misuse-related cases as reported to the European Medicines Agency (EMA) pharmacovigilance database","volume":"10","author":"Chiappini","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.encep.2020.04.006_bib0635","first-page":"145","article-title":"The contributions of lithium and clozapine for the prophylaxis and treatment of suicidal behavior","volume":"Vol. 30","author":"M\u00fcller-Oerlinghausen","year":"2016"},{"issue":"7","key":"10.1016\/j.encep.2020.04.006_bib0640","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2020.04.006_bib0645","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.7150\/ijbs.45120","article-title":"Progression of mental health services during the COVID-19\u00a0outbreak in China","volume":"16","author":"Li","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"5","key":"10.1016\/j.encep.2020.04.006_bib0650","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.alcohol.2007.06.003","article-title":"Alcohol and airways function in health and disease","volume":"41","author":"Sisson","year":"2007","journal-title":"Alcohol"},{"issue":"8","key":"10.1016\/j.encep.2020.04.006_bib0655","doi-asserted-by":"crossref","first-page":"e022344","DOI":"10.1136\/bmjopen-2018-022344","article-title":"Alcohol and the risk of pneumonia: a systematic review and meta-analysis","volume":"8","author":"Simou","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.encep.2020.04.006_bib0660","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/B978-0-444-62619-6.00031-8","article-title":"Alcohol-medical drug interactions","volume":"125","author":"Johnson","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0665","first-page":"12","article-title":"Drug interactions with tobacco smoke: implications for patient care. Savvy Psychopharmacology","volume":"12","author":"Fankhauser","year":"2013","journal-title":"Curr Psychiatry"},{"issue":"11","key":"10.1016\/j.encep.2020.04.006_bib0670","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s40262-016-0400-9","article-title":"Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products","volume":"55","author":"Anderson","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0675","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1345\/aph.1M398","article-title":"Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment","volume":"44","author":"Lowe","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.encep.2020.04.006_bib0680","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ps.55.5.491","article-title":"Atypical antipsychotic dosing: the effect of smoking and caffeine","volume":"55","author":"de Leon","year":"2004","journal-title":"Psychiatr Serv"},{"issue":"3","key":"10.1016\/j.encep.2020.04.006_bib0685","doi-asserted-by":"crossref","first-page":"e004216","DOI":"10.1136\/bmjopen-2013-004216","article-title":"Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine","volume":"4","author":"Tsuda","year":"2014","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.encep.2020.04.006_bib0690","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41397-017-0011-3","article-title":"The impact of genetic polymorphisms on CYP1A2\u00a0activity in humans: a systematic review and meta-analysis","volume":"18","author":"Koonrungsesomboon","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.encep.2020.04.006_bib0695","unstructured":"ANSM 2020 (point d\u2019information COVID-19). https:\/\/www.ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/COVID-19-l-ANSM-prend-des-mesures-pour-favoriser-le-bon-usage-du-paracetamol."},{"key":"10.1016\/j.encep.2020.04.006_bib0700","unstructured":"ANSM. 18\/04\/2019. https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Anti-inflammatoires-non-steroidiens-AINS-et-complications-infectieuses-graves-Point-d-Information."},{"key":"10.1016\/j.encep.2020.04.006_bib0705","series-title":"Anti-inflammatories may aggravate Covid-19, France advises [Internet]","author":"Willsher","year":"2020"},{"key":"10.1016\/j.encep.2020.04.006_bib0710","doi-asserted-by":"crossref","first-page":"m1086","DOI":"10.1136\/bmj.m1086","article-title":"Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists","volume":"368","author":"Day","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.encep.2020.04.006_bib0715","doi-asserted-by":"crossref","first-page":"m1185","DOI":"10.1136\/bmj.m1185","article-title":"Non-steroidal anti-inflammatory drugs and covid-19","volume":"368","author":"Little","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.encep.2020.04.006_bib0720","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3332\/ecancer.2020.1023","article-title":"COVID-19\u00a0and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?","volume":"14","author":"Russell","year":"2020","journal-title":"ecancer"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2020.04.006_bib0725","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.4103\/0976-500X.120975","article-title":"Corticosteroid-related central nervous system side effects","volume":"4","author":"Ciriaco","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0730","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.psym.2011.12.007","article-title":"The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited","volume":"53","author":"Dubovsky","year":"2012","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.encep.2020.04.006_bib0735","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.revmed.2012.12.011","article-title":"Oral glucocorticoid-induced psychiatric side effects: focus on clinical specificities, incidence, risk factors and treatment","volume":"34","author":"Ricoux","year":"2013","journal-title":"Rev Med Interne"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2020.04.006_bib0740","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s00406-014-0537-1","article-title":"Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects","volume":"264","author":"Franke","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.encep.2020.04.006_bib0745","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tcm.2017.07.010","article-title":"CredibleMeds.org: what does it offer?","volume":"28","author":"Woosley","year":"2018","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0750","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","article-title":"Risk factors for QTc prolongation: systematic review of the evidence","volume":"39","author":"Vandael","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.encep.2020.04.006_bib0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.respe.2016.06.335","article-title":"Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case\/non-case analysis in the national pharmacovigilance database","volume":"65","author":"Rochoy","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.encep.2020.04.006_bib0760","unstructured":"HAS. 2019 [mise en ligne 27\u00a0mai 2019]. https:\/\/www.has-sante.fr\/jcms\/c_2966830\/fr\/medicaments-antiemetiques-dans-le-traitement-symptomatique-des-nausees-et-vomissements."},{"issue":"4","key":"10.1016\/j.encep.2020.04.006_bib0765","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/FTD.0b013e3181dad1fb","article-title":"Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993\u20132007","volume":"32","author":"Couchman","year":"2010","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.encep.2020.04.006_bib0770","unstructured":"ANSM 11\/12\/2012. https:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Decongestionnants-de-la-sphere-ORL-renfermant-un-vasoconstricteur-Mise-en-garde-de-l-ANSM-Point-d-information-actualise."},{"key":"10.1016\/j.encep.2020.04.006_bib0775","unstructured":"ANSM 30\/03\/2020. https:\/\/ansm.sante.fr\/S-informer\/Actualite\/Plaquenil-et-Kaletra-les-traitements-testes-pour-soigner-les-patients-COVID-19-ne-doivent-etre-utilises-qu-a-l-hopital-Point-d-information."},{"issue":"5","key":"10.1016\/j.encep.2020.04.006_bib0780","first-page":"155","article-title":"Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: a narrative review based on the study of case reports","volume":"1","author":"Hancox","year":"2013","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"10.1016\/j.encep.2020.04.006_bib0785","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.dsx.2020.03.013","article-title":"Cardiovascular disease and COVID-19","volume":"14","author":"Bansal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.encep.2020.04.006_bib0790","doi-asserted-by":"crossref","first-page":"112902","DOI":"10.1016\/j.psychres.2020.112902","article-title":"The psychiatric impact of the novel coronavirus outbreak","volume":"286","author":"Carvalho","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2020.04.006_bib0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19\u00a0and other coronaviruses","author":"Wu","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.encep.2020.04.006_bib0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2","author":"Moriguchi","year":"2020","journal-title":"Int J Infect Dis"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700620300749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700620300749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:38:41Z","timestamp":1757957921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700620300749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0013700620300749"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2020.04.006","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Informations relatives aux psychotropes et \u00e0 leurs adaptations \u00e9ventuelles pour les patients souffrant de troubles psychiques en France pendant l\u2019\u00e9pid\u00e9mie \u00e0 SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}